BCL2 and acute lymphoblastic leukemia: After treating the EV and ALL, the expression of LC3B-II/LC3B-I was reduced, but the ALL I groups' expression of Bax was not obviously changed (p >0.05 ), and the ALL II group's expression of Bcl2 was increased (p < 0.01).